Technological Prospection in Patent Documents that appoint Fosfoetanolamine as a Substance Associated with Diagnosis, Prevention or Treatment of Any Type of Cancer

The present work shows a prospective study carried out in databases of patent documents on documents that present phosphoethanolamine as a substance associated with the diagnosis, prevention or treatment of some type of cancer. This theme had great repercussion in the years 2015, 2016 and still has...

Descripción completa

Detalles Bibliográficos
Autores: Cerqueira, Tarcísio Magalhães, Silva, Marcelo Miguel da, Ribeiro, Nubia Moura
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:Brasil
Institución:Universidade Federal da Bahia (UFBA)
Repositorio:Cadernos de Prospecção (Online)
Idioma:portugués
OAI Identifier:oai:ojs.periodicos.ufba.br:article/28353
Acceso en línea:https://periodicos.ufba.br/index.php/nit/article/view/28353
Access Level:acceso abierto
Palabra clave:Fosfoetanolamina
Patentes
Prospecção
Phosphoethanolamine
Patents
Prospection.
Descripción
Sumario:The present work shows a prospective study carried out in databases of patent documents on documents that present phosphoethanolamine as a substance associated with the diagnosis, prevention or treatment of some type of cancer. This theme had great repercussion in the years 2015, 2016 and still has repercussions in the present day. All this, by the rumors that a Brazilian chemist had "discovered" the cure of some of the malignant neoplasms, through the use of this substance, in a special synthetic form. The databases used were the National Institute of Industrial Property (INPI), the European Patent Office (ESPACENET) and the ORBIT® software. The results of the research have shown that patent deposits with this theme have existed since 1983, the US leads the domain of this technology, there was a peak of deposits in the year 2014 and the biggest holders of the technology pointed out are legal entities.